Global Defibrillator Market 2023-2029
Defibrillators are devices that send an electric pulse or shock to the heart to restore a normal heartbeat. They are used to prevent or correct an arrhythmia, an uneven heartbeat that is too slow or too fast. Defibrillators can be external, transvenous, or implanted (implantable cardioverter-defibrillator), depending on the type of device used or needed. According to market research study published by Gen Consulting Company, the market size of the global defibrillator sector is expected to rise by USD 6.4 billion with a CAGR of 6.3% by the end of 2029.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global defibrillator market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, end user, and region. The global market for defibrillator can be segmented by product: implantable cardioverter defibrillators (cardiac resynchronization therapy (CRT) defibrillator, transvenous ICD, subcutaneous ICD), external defibrillators (manual, automated, wearable). Globally, the implantable cardioverter defibrillators segment made up the largest share of the defibrillator market. Defibrillator market is further segmented by end user: alternate care facilities, homecare, hospitals & clinics, pre hospital, public access. The hospitals & clinics segment captured the largest share of the market in 2022. Based on region, the defibrillator market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global defibrillator market.
The implantable cardioverter defibrillators market is further segmented into cardiac resynchronization therapy (CRT) defibrillator (CRT-D), subcutaneous ICD (S-ICD), transvenous ICD (T-ICD). The CRT-D segment was the largest contributor to the global defibrillator market in 2022. Furthermore, the external defibrillators market has been categorized into automated external defibrillators, manual external defibrillators, wearable cardioverter defibrillators. The automated external defibrillators segment is estimated to account for the largest share of the global defibrillator market.
Market Segmentation
By product: implantable cardioverter defibrillators (cardiac resynchronization therapy (CRT) defibrillator, transvenous ICD, subcutaneous ICD), external defibrillators (manual, automated, wearable)
By end user: alternate care facilities, homecare, hospitals & clinics, pre hospital, public access
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The global defibrillator market report offers detailed information on several market vendors, including A.M.I. Italia S.r.l., Abbott Laboratories, Advanced Instrumentations Inc., Biotronik SE & Co KG, Boston Scientific Corporation, CU Medical Systems, Inc., Innomed Medical Zrt., Koninklijke Philips N.V., MEDIANA Co., Ltd., medical ECONET GmbH, Medtronic plc, Mindray Medical International Limited, Nanjing Poweam Medical Co., Ltd., Nihon Kohden Corporation (Defibtech LLC), Okuman Medikal Sistemler A.S., Progetti S.r.l., Promed Technology Co., Ltd., SCHILLER AG, Shenzhen Comen Medical Instruments Co., Ltd., Stryker Corporation, WEINMANN Emergency Medical Technology GmbH + Co. KG, Zoll Corp. (Asahi Kasei Co.), among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global defibrillator market.
To classify and forecast the global defibrillator market based on product, end user, region.
To identify drivers and challenges for the global defibrillator market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global defibrillator market.
To identify and analyze the profile of leading players operating in the global defibrillator market.
Why Choose This Report
Gain a reliable outlook of the global defibrillator market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global defibrillator market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, end user, and region. The global market for defibrillator can be segmented by product: implantable cardioverter defibrillators (cardiac resynchronization therapy (CRT) defibrillator, transvenous ICD, subcutaneous ICD), external defibrillators (manual, automated, wearable). Globally, the implantable cardioverter defibrillators segment made up the largest share of the defibrillator market. Defibrillator market is further segmented by end user: alternate care facilities, homecare, hospitals & clinics, pre hospital, public access. The hospitals & clinics segment captured the largest share of the market in 2022. Based on region, the defibrillator market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global defibrillator market.
The implantable cardioverter defibrillators market is further segmented into cardiac resynchronization therapy (CRT) defibrillator (CRT-D), subcutaneous ICD (S-ICD), transvenous ICD (T-ICD). The CRT-D segment was the largest contributor to the global defibrillator market in 2022. Furthermore, the external defibrillators market has been categorized into automated external defibrillators, manual external defibrillators, wearable cardioverter defibrillators. The automated external defibrillators segment is estimated to account for the largest share of the global defibrillator market.
Market Segmentation
By product: implantable cardioverter defibrillators (cardiac resynchronization therapy (CRT) defibrillator, transvenous ICD, subcutaneous ICD), external defibrillators (manual, automated, wearable)
By end user: alternate care facilities, homecare, hospitals & clinics, pre hospital, public access
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The global defibrillator market report offers detailed information on several market vendors, including A.M.I. Italia S.r.l., Abbott Laboratories, Advanced Instrumentations Inc., Biotronik SE & Co KG, Boston Scientific Corporation, CU Medical Systems, Inc., Innomed Medical Zrt., Koninklijke Philips N.V., MEDIANA Co., Ltd., medical ECONET GmbH, Medtronic plc, Mindray Medical International Limited, Nanjing Poweam Medical Co., Ltd., Nihon Kohden Corporation (Defibtech LLC), Okuman Medikal Sistemler A.S., Progetti S.r.l., Promed Technology Co., Ltd., SCHILLER AG, Shenzhen Comen Medical Instruments Co., Ltd., Stryker Corporation, WEINMANN Emergency Medical Technology GmbH + Co. KG, Zoll Corp. (Asahi Kasei Co.), among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global defibrillator market.
To classify and forecast the global defibrillator market based on product, end user, region.
To identify drivers and challenges for the global defibrillator market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global defibrillator market.
To identify and analyze the profile of leading players operating in the global defibrillator market.
Why Choose This Report
Gain a reliable outlook of the global defibrillator market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY PRODUCT
Implantable cardioverter defibrillators (cardiac resynchronization therapy (CRT) defibrillator, transvenous ICD, subcutaneous ICD)
External defibrillators (manual, automated, wearable)
PART 6. MARKET BREAKDOWN BY END USER
Alternate care facilities
Homecare
Hospitals & clinics
Pre hospital
Public access
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 8. KEY COMPANIES
A.M.I. Italia S.r.l.
Abbott Laboratories
Advanced Instrumentations Inc.
Biotronik SE & Co KG
Boston Scientific Corporation
CU Medical Systems, Inc.
Innomed Medical Zrt.
Koninklijke Philips N.V.
MEDIANA Co., Ltd.
medical ECONET GmbH
Medtronic plc
Mindray Medical International Limited
Nanjing Poweam Medical Co., Ltd.
Nihon Kohden Corporation (Defibtech LLC)
Okuman Medikal Sistemler A.S.
Progetti S.r.l.
Promed Technology Co., Ltd.
SCHILLER AG
Shenzhen Comen Medical Instruments Co., Ltd.
Stryker Corporation
WEINMANN Emergency Medical Technology GmbH + Co. KG
Zoll Corp. (Asahi Kasei Co.)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY PRODUCT
Implantable cardioverter defibrillators (cardiac resynchronization therapy (CRT) defibrillator, transvenous ICD, subcutaneous ICD)
External defibrillators (manual, automated, wearable)
PART 6. MARKET BREAKDOWN BY END USER
Alternate care facilities
Homecare
Hospitals & clinics
Pre hospital
Public access
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 8. KEY COMPANIES
A.M.I. Italia S.r.l.
Abbott Laboratories
Advanced Instrumentations Inc.
Biotronik SE & Co KG
Boston Scientific Corporation
CU Medical Systems, Inc.
Innomed Medical Zrt.
Koninklijke Philips N.V.
MEDIANA Co., Ltd.
medical ECONET GmbH
Medtronic plc
Mindray Medical International Limited
Nanjing Poweam Medical Co., Ltd.
Nihon Kohden Corporation (Defibtech LLC)
Okuman Medikal Sistemler A.S.
Progetti S.r.l.
Promed Technology Co., Ltd.
SCHILLER AG
Shenzhen Comen Medical Instruments Co., Ltd.
Stryker Corporation
WEINMANN Emergency Medical Technology GmbH + Co. KG
Zoll Corp. (Asahi Kasei Co.)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
